&nbsp;

view-print-pcir-01.png

Jun 2024

Document

view-print-pcir-02.png

Jun 2024

Regimen

NIVL+RELA

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab and Relatlimab - Advanced Melanoma (Unresectable or Metastatic Melanoma)

Drugs Used:

nivolumab / relatlimab

Quick Link(s):

Regimen Monograph

Nov 2024

Document

Vaginal-Vault-Testing-FAQs.pdf

Aug 2024

Document

no-harm.png

Sep 2024

Regimen

NPAC(W)

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes

Drugs Used:

nab-PACLitaxel

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

NPAC

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes

Drugs Used:

nab-PACLitaxel

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

NPAC(W)

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes

Drugs Used:

nab-PACLitaxel